TLR4 and coronary artery disorder: In the LGG trial, LPS fell markedly in the probiotic arm versus a placebo [33], and a combination therapy using an inulin prebiotic plus a Lactobacillus probiotic led to a ~30% drop in LPS alongside down-regulation of Toll-like receptor 4 (TLR4) expression in CAD patients [32].